Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Chandrashekhar, Bolmall"'
Autor:
Arvind B Goregaonkar, Akhilesh Sharma, Praveen Taneja, K.J. Mathiazhagan, Vidyagauri P. Baliga, Paramjeet Singh Kapoor, Ravindra R. Shah, Chandrashekhar Bolmall
Publikováno v:
Current Therapeutic Research. 70:56-68
Background: Reports of cardiovascular adverse events (AEs) associated with the use of cyclooxygenase-2 inhibitors for the treatment of osteoarthritis (OA) have prompted the quest for a better-tolerated NSAID. Objective: The aim of this study was to c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c98c66dae5ddd8cc38672742819bee00
https://doi.org/10.1016/j.curtheres.2009.02.006
https://doi.org/10.1016/j.curtheres.2009.02.006
Autor:
R, Balasubramanian, S, Varadharajan, Ashish, Kathale, L M, Nagraj, I, Periyandavar, Uday P, Nayak, Akhilesh, Sharma, Chandrashekhar, Bolmall, Vidyagauri P, Baliga
Publikováno v:
Journal of the Indian Medical Association. 106(7)
Type 2 diabetes mellitus is associated with a marked increase in the risk of coronary heart disease (CHD) or stroke (by a factor of two to three compared with non-diabetic patients), and cardiovascular disease (CVD) accounts for the majority of death
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::55f28b87769e570e63f00a32a025f7ae
https://pubmed.ncbi.nlm.nih.gov/18975505
https://pubmed.ncbi.nlm.nih.gov/18975505